These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19493055)
1. Introduction: The first Merinoff Symposium, 'Systemic Lupus: Bringing Science to the Patient'. Batliwalla F; Tracey KJ J Intern Med; 2009 Jun; 265(6):622-4. PubMed ID: 19493055 [No Abstract] [Full Text] [Related]
2. How long does it take to describe 25 SLE antigen/antibody systems? Alarcón-Segovia D Lupus; 1999; 8(4):332. PubMed ID: 10413215 [No Abstract] [Full Text] [Related]
3. The large print giveth and the small print taketh away: preemptive treatment of serologically active, clinically quiet systemic lupus erythematosus. Liang MH; Simard JF Arthritis Rheum; 2006 Nov; 54(11):3378-80. PubMed ID: 17075813 [No Abstract] [Full Text] [Related]
4. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production. Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF Front Immunol; 2020; 11():1047. PubMed ID: 32625200 [TBL] [Abstract][Full Text] [Related]
5. Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus. Arita K; Murakami J; Wada A; Miyazono T; Sugiyama T Bone Marrow Transplant; 2016 Jun; 51(6):883-4. PubMed ID: 26901706 [No Abstract] [Full Text] [Related]
6. Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study. Pfueller B; Wolbart K; Bruns A; Burmester GR; Hiepe F Arthritis Rheum; 2001 Aug; 44(8):1962-3. PubMed ID: 11508450 [No Abstract] [Full Text] [Related]
7. Molecular mimicry in systemic lupus erythematosus. Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic CD154 antibody for lupus: promise for the future? Kelsoe G J Clin Invest; 2003 Nov; 112(10):1480-2. PubMed ID: 14617748 [TBL] [Abstract][Full Text] [Related]
10. Re-establishment of tolerance: the prospect of developing specific treatment for human lupus. Katsiari CG; Tsokos GC Lupus; 2004; 13(7):485-8. PubMed ID: 15352417 [No Abstract] [Full Text] [Related]
11. [Advances in Autoantibodies against C-reactive Protein in Systemic Lupus Erythematosus]. Li QY; Yu F Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):678-684. PubMed ID: 31699200 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic modalities in systemic lupus erythematosus. Tyagi NK; Lahita RG Saudi Med J; 2013 Sep; 34(9):887-95. PubMed ID: 24042998 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Ghirardello A; Doria A; Zampieri S; Gambari PF; Todesco S Isr Med Assoc J; 2001 Nov; 3(11):854-7. PubMed ID: 11729585 [No Abstract] [Full Text] [Related]
16. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematodes and their clinical significance. III. RNA-fixing autoantibodies, ribonucleoprotein autoantibodies]. Wollina U Allerg Immunol (Leipz); 1983; 29(4):191-9. PubMed ID: 6198890 [TBL] [Abstract][Full Text] [Related]
17. Lepromatous leprosy complicated with systemic lupus erythematosus. Ohkawa S; Ozaki M; Izumi S Dermatologica; 1985; 170(2):80-3. PubMed ID: 3979635 [TBL] [Abstract][Full Text] [Related]